Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on SalesTimes Interest Earned

PAVmed (PAVM) Gross Margin (2021 - 2025)

PAVmed has reported Gross Margin over the past 5 years, most recently at 867.9% for Q4 2025.

  • Quarterly results put Gross Margin at 867.9% for Q4 2025, up 58210.0% from a year ago — trailing twelve months through Dec 2025 was 1027.0% (down 23370.0% YoY), and the annual figure for FY2025 was 817.0%, down 52879.0%.
  • Gross Margin for Q4 2025 was 867.9% at PAVmed, up from 1000.0% in the prior quarter.
  • Over the last five years, Gross Margin for PAVM hit a ceiling of 28.0% in Q3 2021 and a floor of 6131.58% in Q3 2022.
  • Median Gross Margin over the past 5 years was 725.62% (2025), compared with a mean of 1408.24%.
  • Biggest five-year swings in Gross Margin: tumbled -615958bps in 2022 and later surged 600667bps in 2023.
  • PAVmed's Gross Margin stood at 47.0% in 2021, then tumbled by -10628bps to 5041.96% in 2022, then surged by 78bps to 1117.73% in 2023, then dropped by -30bps to 1450.0% in 2024, then surged by 40bps to 867.9% in 2025.
  • The last three reported values for Gross Margin were 867.9% (Q4 2025), 1000.0% (Q3 2025), and 583.33% (Q2 2025) per Business Quant data.